Predicting how anesthetic drugs bind to cell membrane proteins
Efficient prediction of transmembrane binding sites for anesthetic ligands
This study is looking at how anesthesia works in the body by figuring out where anesthetic drugs attach to proteins in cell membranes, which could help make anesthesia safer and more effective for patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10903722 on NIH RePORTER |
What this research studies
This research focuses on understanding how anesthetic drugs interact with proteins in cell membranes, which is crucial for their effectiveness. By using advanced computational methods, the project aims to identify the specific sites on these proteins where anesthetics bind, particularly in challenging areas known as transmembrane domains. The researchers will enhance existing molecular docking techniques to better account for the complex lipid environment surrounding these proteins. This approach could lead to more accurate predictions of drug interactions, ultimately improving anesthetic practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing procedures that require anesthesia, particularly those with specific cardiovascular considerations.
Not a fit: Patients who are not undergoing anesthesia or those with conditions unrelated to anesthetic drug interactions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective anesthetic drugs by providing insights into how they bind to their target proteins.
How similar studies have performed: Previous research has shown promise in using computational methods to predict drug binding sites, indicating that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Joseph, Thomas Thenganpallil — University of Pennsylvania
- Study coordinator: Joseph, Thomas Thenganpallil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.